L
Lineage Cell Therapeutics Inc
TASE:LCTX
Lineage Cell Therapeutics Inc
TASE:LCTX
Price:
495
ILS
-0.04%
Market Closed
Market Cap:
₪391.4m
Wall Street
Price Targets
LCTX Price Targets Summary
Lineage Cell Therapeutics Inc
Lineage Cell Therapeutics Inc
Wall Street analysts forecast LCTX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for LCTX is 1 336 ILS with a low forecast of 634.99 ILS and a high forecast of 2 970.61 ILS.
Lowest
Price Target
634.99
ILS
28% Upside
Average
Price Target
1 336
ILS
170% Upside
Highest
Price Target
2 970.61
ILS
500% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LCTX's stock price target?
Price Target
1 336
ILS
1 336
ILS
According to Wall Street analysts, the average 1-year price target for LCTX is 1 336 ILS with a low forecast of 634.99 ILS and a high forecast of 2 970.61 ILS.
What is Lineage Cell Therapeutics Inc's Revenue forecast?
Projected CAGR
60%
60%
For the last 14 years the compound annual growth rate for Lineage Cell Therapeutics Inc's revenue is 9%. The projected CAGR for the next 3 years is 60%.
